The markets on November 9, 2018 opened positive. BSE Sensex is trading at 35,210.50, Down by 27.18 points and the Nifty is trading at 10,600.10, up by 1.70 points. 

Strides Pharma’s wholly-owned subsidiary, Strides Pharma Global Pte Limited, Singapore signed a partnership agreement with SUDA Pharmaceuticals Limited for the exclusive product development, licensing and supply of sumatriptan in the US market.

The company has received a Letter of award (LoA) for upgrading, two laning of roads with pavement shoulder from PWD department of Maharashtra state.

Overall volumes in futures & options currently stand at 14, 20,610 contracts with a turnover of Rs. 74,455.46.

Overall volumes in futures & options currently stand at 14, 20,610 contracts with a turnover of Rs. 74,455.46.

The company's wholly-owned subsidiary acquired Stelligent Systems, LLC for a consideration of US$ 25 million on Thursday.

Going ahead, the zone of 10,610-10,710 is likely to act as a strong resistance zone. On the other hand, the zone of 10,440-10,500 is likely to act as a strong support zone. Stocks in news: Glenmark Pharmaceuticals, JSW Steel, Gail, Mphasis, Majesco and PNB.

India markets may open slightly lower on Friday following negative sentiments prevailing in the Asian markets and mixed close on the Wall Street. The SGX Nifty Index Future, which was trading at 10,585, suggests Nifty may open lower by 31 points. On the earnings front, Titan, India Cements, EID Parry, Amara Raja Batteries, Indian Bank will release their results today.  

Mutual fund Update: Two-third of retail investors remain invested for more than a year in mutual funds. Most of the retail investor remain invested for more than one year, both in equity as well as non-equity funds.

Leading biopharma company, Suven Life Sciences Limited announced the grant of one product patent from Israel and one product patent from Japan new chemical compounds for the treatment of neurodegenerative diseases.